Feasibility of a mass vaccination campaign using a two-dose oral cholera vaccine in an urban cholera-endemic setting in Mozambique

Vaccine

Volumn 24, Issue 22, 2006, Pages 4890-4895

  Cavailler, Philippe ^a   Lucas, Marcelino ^b   Perroud, Valerie ^c   McChesney, Margaret ^c   Ampuero, Sonia ^c   Guérin, Philippe J ^a   Legros, Dominique ^a   Nierle, Thomas ^c   Mahoudeau, Claude ^c   Lab, Bruno ^c   Kahozi, Pierre ^d   Deen, Jacqueline L ^e   von Seidlein, Lorenz ^e   Wang, Xuan Yi ^e   Puri, Mahesh ^e   Ali, Mohammad ^e   Clemens, John D ^e   Songane, Francisco ^b   Baptista, Alberto ^b   Ismael, Fauzia ^b   Barreto, Avertino ^b   Chaignat, Claire Lise ^d   more..

^a EPICENTRE   (France)

^b Ministerio da Saude   (Mozambique)

^c MÉDECINS SANS FRONTIÈRES   (Switzerland)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e International Vaccine Institute   (South Korea)

Author keywords

Cholera; Cost; Mass vaccination; Mozambique

Indexed keywords

CHOLERA VACCINE;

ABDOMINAL PAIN; ARTICLE; CHILD; CHOLERA; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DOSE RESPONSE; DRUG COST; DRUG INFORMATION; ENDEMIC DISEASE; FEASIBILITY STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS IMMUNIZATION; MOZAMBIQUE; NAUSEA; PRIORITY JOURNAL; SIDE EFFECT; TASTE AVERSION; UNSPECIFIED SIDE EFFECT; URBAN AREA; WEAKNESS;

ADMINISTRATION, ORAL; ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHOLERA; COSTS AND COST ANALYSIS; FEMALE; HUMANS; MALE; MASS IMMUNIZATION; MOZAMBIQUE;

EID: 33646901836     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.10.006     Document Type: Article

References (14)

1. WHO Cholera. Week Epidemiol Record 79 (2004) 281-288
2. Global Task Force on Cholera Control. Cholera vaccines: a new public health tool? Report of a WHO meeting. Geneva: World Health Organization; 10-11 December 2002. WHO/CDS/CPE/ZFK/2004.5.
3. Legros D., Paquet C., Perea W., Marty I., Mugisha N.K., Royer H., et al. Mass vaccination with a two dose oral cholera vaccine in a refugee camps. Bull World Health Org 77 10 (1999) 837-842
4. Global Task Force on Cholera Control: Report on Cholera Control Programme in Mozambique. Geneva: World Health Organization; June 2003.
5. Clemens J.D., Sack D.A., Harris J.R., Chakraborty J., Khan M.R., Stanton B.F., et al. Field trial of cholera vaccine in Bangladesh. Lancet 19 2 (1986) 24-27
6. Clemens J.D., Sack D.A., Harris J.R., Van Loon F., Chakraborty J., Ahmed F., et al. Field trials of cholera vaccines in Bangladesh: results from a three year follow-up. Lancet 335 (1990) 270-273
7. Sanchez J.L., Vasquez B., Begue R.E., Meza R., Castellares G., Cabezas C., et al. Protective efficacy of the oral whole cell/recombinant B subunit cholera vaccine in Peruvian military recruits. Lancet 344 (1994) 1273-1276
8. Lucas M.E., Deen J.L., von Seidlein L., Wang X.Y., Ampuero J., Puri M., et al. Effectiveness of mass oral cholera vaccination in Beira, Mozambique. N Engl J Med 352 8 (2005 Feb 24) 757-767
9. Holmgren J., and Bergquist C. Oral B subunit killed whole-cell cholera vaccine. In: Levine M.M., Kaper J.B., Liu M.A., Rappuoli R., and Good M.F. (Eds). New-generation vaccines (2004), Marcel Dekker, NY, USA 499-510
10. Epi-Info, Version 6.04b. Atlanta, GA, USA: Centers for Disease Control and Prevention. Geneva: WHO.
11. SPSS, Version 11.5. Chicago, IL, USA: SPSS Inc.
12. Thiem V.D., Hossain M.M., Son N.D., Hoa N.T., Rao M.R., Canh D.G., et al. Coverage and cost of mass immunization of an oral cholera vaccine in Vietnam. J Health Populat Nutr 4 (2003) 304-308
13. Conduite à tenir en cas d'épidémie de méningite à méningocoque [What to do when faced with an epidemic of meningococcal meningitis]. Paris: Médecins sans Frontières; 1993.
14. Sack D.A., Sack B., Nair G.B., and Siddique A.K. Cholera. Lancet 363 (2004) 223-233